Literature DB >> 1904192

Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity.

J M Hourani1, P E Bellamy, D P Tashkin, P Batra, M S Simmons.   

Abstract

PURPOSE: Abnormalities in pulmonary function have been reported in association with chronic liver disease of varied etiology. The aim of this study was to better define the frequency and nature of these abnormalities in patients who were being evaluated for liver transplantation. PATIENTS AND METHODS: We performed a battery of pulmonary function tests and chest radiographs in 116 consecutive patients (50 men, 66 women; aged 19 to 70 years, mean 44.6 years) with severe advanced liver disease who were hospitalized specifically for evaluation for possible orthotopic liver transplantation and were able to perform technically satisfactory tests. In 17 patients, quantitative whole-body technetium-99m macroaggregated albumin perfusion scanning was also performed for assessment of possible right-to-left shunting through intrapulmonary vascular dilatations.
RESULTS: The most commonly affected test of lung function was the single-breath diffusing capacity for carbon monoxide (DLCO), which was abnormal in 48%, 45%, and 71% of patients who never smoked, former smokers, and current smokers, respectively. Ventilatory restriction was noted in 25% of all patients, airflow obstruction (reduced ratio of forced expiratory volume in 1 second to forced vital expiratory volume in 1 second to forced vital capacity) in only 3%, and a widened alveolar-arterial oxygen gradient in 45%. Diffusion impairment was accompanied by a restrictive defect in only 35% of the patients and by an abnormally widened alveolar-arterial oxygen gradient in 60%. When diffusion impairment was accompanied by an oxygenation defect, it was also associated with a significantly increased right-to-left shunt fraction (mean 24.9%) assessed from quantitative whole-body perfusion imaging. On the other hand, isolated diffusion impairment unaccompanied by significant hypoxemia (noted in approximately a third of the patients with a reduced DLCO) was not associated with evidence of significant intrapulmonary shunting (mean right-to-left shunt fraction 6.7%).
CONCLUSIONS: Most patients with advanced liver disease have one or more types of abnormality in lung function, a reduced DLCO being the single most common functional defect. Mechanisms accounting for the abnormality in gas transfer may include intrapulmonary vascular dilatations, diffuse interstitial lung disease, pulmonary vaso-occlusive disease, and/or ventilation-perfusion imbalance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904192

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  24 in total

1.  Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.

Authors:  Matthew R Gingo; Mehdi Nouraie; Cathy J Kessinger; Ruth M Greenblatt; Laurence Huang; Eric C Kleerup; Lawrence Kingsley; Deborah K McMahon; Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2018-02

2.  Pulmonary evaluation in pediatric liver transplant candidates.

Authors:  Seyed Mohsen Dehghani; Soheyla Aleyasin; Naser Honar; Ahad Eshraghian; Sara Kashef; Mahmood Haghighat; Seyed Ali Malek-Hosseini
Journal:  Indian J Pediatr       Date:  2010-10-02       Impact factor: 1.967

3.  Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation.

Authors:  Graciela Martínez-Palli; Federico P Gómez; Joan A Barberà; Miquel Navasa; Josep Roca; Robert Rodríguez-Roisin; Felip Burgos; Conchi Gistau
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

4.  Portopulmonary hypertension.

Authors:  Ravi P Nayak; Dechun Li; George M Matuschak
Journal:  Curr Gastroenterol Rep       Date:  2009-02

5.  Diagnosis of hepatopulmonary syndrome with contrast transesophageal echocardiography: advantages over contrast transthoracic echocardiography.

Authors:  R Aller; J L Moya; V Moreira; D Boixeda; A Cano; J Picher; S García-Rull; D A de Luis
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

6.  Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences.

Authors:  P Schenk; V Fuhrmann; C Madl; G Funk; S Lehr; O Kandel; C Müller
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

7.  Development of hypoxemia in alcoholic liver disease.

Authors:  Shigeo Maruyama; Chisato Hirayama; Kazunori Maeda; Satoru Yamamoto; Masaharu Koda; Akihide Udagawa; Masayuki Inoue; Kensuke Umeki
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

8.  Continuous and intermittent cardiac output measurement in hyperdynamic conditions: pulmonary artery catheter vs. lithium dilution technique.

Authors:  Maria Gabriella Costa; Giorgio Della Rocca; Paolo Chiarandini; Silvia Mattelig; Livia Pompei; Mauricio Sainz Barriga; Toby Reynolds; Maurizio Cecconi; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2007-10-06       Impact factor: 17.440

9.  Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia.

Authors:  Hui-Ying Zhang; De-Wu Han; Zhong-Fu Zhao; Ming-She Liu; Yan-Jun Wu; Xian-Ming Chen; Cheng Ji
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

10.  Dyspnea and respiratory muscle strength in end-stage liver disease.

Authors:  Georgios Kaltsakas; Efstathios Antoniou; Anastasios F Palamidas; Sofia-Antiopi Gennimata; Panorea Paraskeva; Anastasios Smyrnis; Antonia Koutsoukou; Joseph Milic-Emili; Nickolaos G Koulouris
Journal:  World J Hepatol       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.